SXTP insider trading
NasdaqCM Healthcare60 DEGREES PHARMACEUTICALS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About 60 DEGREES PHARMACEUTICALS, INC.
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia.
Company website: www.60degreespharma.com
SXTP insider activity at a glance
FilingIQ has scored 38 insider transactions for SXTP since Jul 28, 2023. The most recent filing in our index is dated Jun 12, 2026.
Across the full history, 22 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on SXTP insider trades is 64.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest SXTP Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for SXTP?
- FilingIQ tracks 38 Form 4 insider transactions for SXTP (60 DEGREES PHARMACEUTICALS, INC.), covering filings from Jul 28, 2023 onwards. 1 of those were filed in the last 90 days.
- Are SXTP insiders net buyers or net sellers?
- Across the full Form 4 history for SXTP, 22 transactions (58%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SXTP insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is SXTP in?
- 60 DEGREES PHARMACEUTICALS, INC. (SXTP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $3.71M.
Methodology & sources
Every SXTP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.